Reuben Tooze

8.2k total citations · 1 hit paper
64 papers, 2.5k citations indexed

About

Reuben Tooze is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Reuben Tooze has authored 64 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 25 papers in Molecular Biology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Reuben Tooze's work include Lymphoma Diagnosis and Treatment (20 papers), Immune Cell Function and Interaction (18 papers) and T-cell and B-cell Immunology (14 papers). Reuben Tooze is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Immune Cell Function and Interaction (18 papers) and T-cell and B-cell Immunology (14 papers). Reuben Tooze collaborates with scholars based in United Kingdom, United States and Egypt. Reuben Tooze's co-authors include Gina M. Doody, Douglas T. Fearon, Matthew A. Care, Sophie Stephenson, David R. Westhead, Sharon Barrans, Valerie Horsley, Martin Turner, Elaine Fuchs and Tetyana V. Obukhanych and has published in prestigious journals such as Cell, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Reuben Tooze

58 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

2020 260 citations Stuart Lacy, Sharon Barrans et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reuben Tooze United Kingdom	26	1.0k	1.0k	555	496	271	64	2.5k
Mats Ehinger Sweden	30	426 0.4×	1.5k 1.5×	558 1.0×	847 1.7×	761 2.8×	86	3.2k
Mark Lupher United States	27	1.3k 1.3×	1.6k 1.6×	127 0.2×	596 1.2×	239 0.9×	38	3.4k
Lee N. Lawton United States	18	397 0.4×	1.9k 1.9×	164 0.3×	357 0.7×	139 0.5×	29	2.6k
Hui C. Tsou United States	19	266 0.3×	2.1k 2.1×	484 0.9×	597 1.2×	193 0.7×	37	2.9k
Ignacio Moreno de Alborán Spain	19	604 0.6×	1.4k 1.4×	178 0.3×	656 1.3×	124 0.5×	31	2.2k
Pierre Vaigot France	22	361 0.3×	841 0.8×	100 0.2×	301 0.6×	158 0.6×	51	1.7k
Kevin Barton United States	21	1.0k 1.0×	1.8k 1.8×	363 0.7×	722 1.5×	261 1.0×	50	3.2k
Håkan Hedman Sweden	28	493 0.5×	1.5k 1.5×	102 0.2×	601 1.2×	222 0.8×	71	2.3k
Iris Moll Germany	19	543 0.5×	1.3k 1.3×	128 0.2×	881 1.8×	156 0.6×	28	2.5k
Abel Sánchez‐Aguilera Spain	21	485 0.5×	1.0k 1.0×	508 0.9×	646 1.3×	564 2.1×	31	2.2k

Countries citing papers authored by Reuben Tooze

Since Specialization

Citations

This map shows the geographic impact of Reuben Tooze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben Tooze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben Tooze more than expected).

Fields of papers citing papers by Reuben Tooze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuben Tooze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben Tooze. The network helps show where Reuben Tooze may publish in the future.

Co-authorship network of co-authors of Reuben Tooze

This figure shows the co-authorship network connecting the top 25 collaborators of Reuben Tooze. A scholar is included among the top collaborators of Reuben Tooze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuben Tooze. Reuben Tooze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Alexandra, Clare Frobisher, Abraham Varghese, et al.. (2025). COVID ‐19‐related mortality in a real‐world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK 's Haematological Malignancy Research Network. British Journal of Haematology. 208(2). 486–497.

Stephenson, Sophie, Matthew A. Care, Roger G. Owen, et al.. (2025). Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation. Life Science Alliance. 8(10). e202402814–e202402814. 1 indexed citations

Stephenson, Sophie, Gina M. Doody, Amy MacDougall, et al.. (2024). Effects of cladribine on intrathecal and peripheral B and plasma cells. Clinical & Experimental Immunology. 219(1).

Lamb, Maxine, Daniel Painter, Debra Howell, et al.. (2023). Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research Network. Cancer Epidemiology. 88. 102513–102513. 10 indexed citations

Care, Matthew A., Sophie Stephenson, Roger G. Owen, Gina M. Doody, & Reuben Tooze. (2023). Spontaneous EBV-Reactivation during B Cell Differentiation as a Model for Polymorphic EBV-Driven Lymphoproliferation. Cancers. 15(12). 3083–3083.

Crouch, Simon, Daniel Painter, Sharon Barrans, et al.. (2022). Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Advances. 6(21). 5716–5731. 17 indexed citations

Lacy, Stuart, Sharon Barrans, Philip Beer, et al.. (2020). Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 135(20). 1759–1771. 260 indexed citations breakdown →

Glover, Paul, Chulin Sha, Matthew A. Care, et al.. (2020). Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance. British Journal of Haematology. 192(3). 599–604. 6 indexed citations

Lara‐Reyna, Samuel, James A. Poulter, Elton J. R. Vasconcelos, et al.. (2020). Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology. 41(2). 441–457. 4 indexed citations

10.

El‐Sherbiny, Yasser M., Md Yuzaiful Md Yusof, Antonios Psarras, et al.. (2019). B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 72(5). 769–779. 16 indexed citations

11.

El‐Sherbiny, Yasser M., Antonios Psarras, Md Yuzaiful Md Yusof, et al.. (2018). A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports. 8(1). 5793–5793. 68 indexed citations

12.

New, Maria I., Heidi Olzscha, Marie‐Laëtitia Thézénas, et al.. (2016). TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism. Cancer Research. 76(23). 6975–6987. 31 indexed citations

13.

Doody, Gina M., Matthew A. Care, Nicholas J. Burgoyne, et al.. (2010). An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Research. 38(16). 5336–5350. 51 indexed citations

14.

Barnes, Nicholas A., Sophie Stephenson, Reuben Tooze, & Gina M. Doody. (2009). Amino Acid Deprivation Links BLIMP-1 to the Immunomodulatory Enzyme Indoleamine 2,3-Dioxygenase. The Journal of Immunology. 183(9). 5768–5777. 14 indexed citations

15.

Maestre, Lorena, Reuben Tooze, Marta Cañamero, et al.. (2009). Expression pattern of XBP1(S) in human B-cell lymphomas. Haematologica. 94(3). 419–422. 25 indexed citations

16.

Doody, Gina M., et al.. (2007). PRDM1/BLIMP-1 Modulates IFN-γ-Dependent Control of the MHC Class I Antigen-Processing and Peptide-Loading Pathway. The Journal of Immunology. 179(11). 7614–7623. 34 indexed citations

17.

Tooze, Reuben, Sophie Stephenson, & Gina M. Doody. (2006). Repression of IFN-γ Induction of Class II Transactivator: A Role for PRDM1/Blimp-1 in Regulation of Cytokine Signaling. The Journal of Immunology. 177(7). 4584–4593. 25 indexed citations

18.

Horsley, Valerie, Dónal O’Carroll, Reuben Tooze, et al.. (2006). Blimp1 Defines a Progenitor Population that Governs Cellular Input to the Sebaceous Gland. Cell. 126(3). 597–609. 329 indexed citations

19.

Tooze, Reuben, Martin Turner, David Sandoval, et al.. (1998). CD19 as a Membrane-Anchored Adaptor Protein of B Lymphocytes: Costimulation of Lipid and Protein Kinases by Recruitment of Vav. Immunity. 8(5). 635–645. 155 indexed citations

20.

Tooze, Reuben, Gina M. Doody, & Douglas T. Fearon. (1997). Counterregulation by the Coreceptors CD19 and CD22 of MAP Kinase Activation by Membrane Immunoglobulin. Immunity. 7(1). 59–67. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact